The global radiation shielding material market is expected to reach $980 million by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The growth is driven by the increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, as well as the growing use of particle therapy for cancer treatment. However, factors like lack of adequate healthcare infrastructure, shortage of skilled oncologists/radiologists, and no mandate for using lead aprons during dental x-ray procedures in the US are hindering market growth. The market is dominated by North America, where there is a focus on government and private investments to meet the demand for cancer treatment. Some key players in the market include ETS-LINDGREN, Nelco worldwide, Infab Corporation, and Burlington Medical.
Tue, 26 Sep 2023 01:17:57 GMT | Digital Journal